The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Executive Vice-President of Diagnostics, Africa, at Roche Diagnostics, Dr. Allan Pamba ... to diagnostics and integrating self-monitoring into routine care, enabling us to control our health,” he said ...

These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

Kazmierczak also appreciates that flexibility. “Roche provides phenomenal work-life balance, with great benefits, making it ...

Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...

WHO approves first mpox diagnostic test for emergency ... treat patients with multiple sclerosis. Stories on US FDA approving injectable Roche multiple sclerosis therapy are withdrawn September ...

In some respects, the new approval is a key milestone for Roche, coming after years of effort at the diagnostics giant to ... to other players in the US digital pathology market, notably Philips ...

diagnostics, and flavours and fragrances. In 1982, the United States arm of Roche acquired Biomedical Reference Laboratories, for US $163.5 million. That same year, Roche merged all of its ...